1Gholam C, Grigoriadou S, Gilmour KC, et al.Familial haemo- phagocytic lymphohistiocytosis: advances in the genetic basis, diagnosis and management [J].Clin Exp Immunol, 2011, 163 (3) :271-283.
2Gurgey A, Gogus S, Ozyurek E, et al.Primary hemophagocytic lymphohistiocytosis in Turkish children[J].Pediatr Hematol On- col, 2003,20: 367-371.
3Coo HW, Weon YC.A spectrum of neuroradiological findings in children with haemophagocytic lymphohistiocytosis [J].Pediatr Radiol,2007,37 : 1110-1117.
4Home A, Trottestam H, Arico M, et al.Frequency and spectrum of central nervous system involvement in 193 children with hae- mophagocytic lymphohistiocytosis [ J ].Br J Haematol, 2008,140: 327-335.
5Shinoda J, Murase S, Takenaka K, et al.Isolated central nervous system hemophagocytic lymphohistiocytosis: case report [ J ] .Neu- rosurgery,2005,56: E187-190.
7Sparber-Sauer M, Honig M, Schulz AS, et al.Patients with early relapse of primary hemophagocytic syndromes or with persistent CNS involvement may benefit from immediate hematopoietic stem cell transplantation [J].Bone Marrow Transplantation, 2009,44 : 333-338.
8Imashuku S, Hyakuna N, Funabiki T, et al.Low natural killer ac- tivity and central nervous system disease as a high risk prognos- tic indicator in young patients with hemophagocytic lymphohis- tiocytosis [ J ] .Cancer, 2002,94: 3023-3031.
9Trapani JA, Voskoboinik I.Infective, neoplastic, homeostatic.se- quelae of the loss of perforin function in humans [J].Adv Exp Med Biol, 2007,601 : 235-242.
10Marc T, Marina C, Stephane B, et al.Hematopoietic stem cell transplantation in hemophagocytic lymphohistiocytosis: a sin- gle center report of 48 patients [J].Pediatfics, 2006, 117 (4) : 743-750.
2Kimura H, Ito Y, Suzuki R, et al. Measuring Epstein-Barr virus (EBV) load: the significance and application for each EBV-associated disease [J]. Rev Med Virol, 2005, 18: 305-319.
4Nagafuji K, Nonami A, Kumano T, et al. Perfofin gene mutations in adult-onset hemophagocytic lymphohistiocytosis [J]. Haematologica, 2007, 92 (7) : 978-981.
5Sato S, Kawashima H, Oshiro H, et al. Virological and immunological characteristics of a 19-year-old Japanese female with fatal outcome with Epstein-Barr virus-associated hemophagocytic syndrome[J]. J CIin Virol,2004,31 : 235-238.
6Kasahara Y, Yachie A. Cell type specific infection of Epstein-Barr virus (EBV) in EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection [J]. Crit Rev Oncol Hematol, 2002,44: 283-294.
7Shinsaka I. Clinical features and treatment strategies of EpsteinJ Barr virus-associated hemophagocytic lymphohistincytosis [J ]. Critic Rev Oncol/Hematol, 2002, 44: 259-272.
8Tabata Y, Hibi S, Teramura T, et al. Molecular analysis of latent membrane protein 1 in patients with Epstein /Barr virus-associated hemophagocytic lymphohistiocytosis in Japan [J]. Leuk Lymphoma, 2000,38 : 373-380.
9Jin YK, Xie ZD, Lu G, el al. Characterization of variants in the promoter of BZLF1 gene of EBV in nonmalignant EBV-associated diseases in Chinese children[J]. Virol J, 2010, 7:92.
10Chuang HC, Lay JD, Hsieh WC, et al. Epstein-Barr virus LMP1 inhibits the expression of SAP gene and upregulates Thl cytokines in the pathogenesis of hemophagocytic syndrome [J]. Blood,2005, 106(9) : 3090-3096.
6Weitzman S. Approach to hemophagocytic syndromes. Hematol- ogy Am Soc Hematol Educ Program,2011,2011 ( 1 ) :178-183.
7Chan JS, Shing MM, Lee V, et al. Haemophagocytic lymphohis- tiocytosis in Hong Kong children. Hong Kong Med J,2008,14 (4) :308-313.
8Verbsky JW, Grossman WJ. Hemophagocytic lymphohistiocyto- sis: diagnosis, pathophysiology, treatment, and future perspec- tives. Ann Meal,2006,38( 1 ) :20-31.
9Trottestam H, Berglof E, Home A, et al. Risk factors for early death in children with haemophagocytic lymphohistiocytosis. Acta Paediatr,2012,101 (3) :313-318.
10Henter Jl, Home A, A_rico M, et al. HLH-2004 : Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer,2007,48 ( 2 ) : 124-131.
